Candel Therapeutics Grants 63,000 Options at $8.30 Exercise Price
CADL•Candel Therapeutics granted inducement stock options to three new employees to purchase an aggregate of 63,000 shares with an $8.30 exercise price under its 2025 Inducement Plan. These options vest 25% after one year of service and the remaining 75% in 36 equal monthly installments, subject to continued employment.
1. Grant Details
On May 31, 2026, the Compensation Committee granted inducement stock options to three new employees to purchase an aggregate of 63,000 shares of common stock at an exercise price of $8.30 per share.
2. Vesting Schedule
The awards vest 25% on the first anniversary of each employee’s start date, with the remaining 75% vesting in 36 equal monthly installments, contingent on continued service.
3. Plan Background
The grants were made under the company’s 2025 Inducement Plan, adopted December 24, 2025, in compliance with Nasdaq Listing Rule 5635(c)(4) as material inducements for new hires.
